Octamer Overview

  • Year Founded
  • 1990

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

Octamer General Information

Description

Developer of healthcare company designed to treat various inflammatory diseases. The company develops drugs that specifically attack tumor cells of individuals suffering from acute inflammatory diseases including cancer and AIDS, enabling patients to recover from inflammatory diseases.

Contact Information

Website
www.octamer.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly Angel backed
Corporate Office
  • 392 Cecilia Way
  • Belvedere Tiburon, CA 94920
  • United States
+1 (415)
Primary Industry
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 392 Cecilia Way
  • Belvedere Tiburon, CA 94920
  • United States
+1 (415)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Octamer Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private Completed Generating Revenue
1. Angel (individual) 17-Sep-2009 Completed Generating Revenue
To view Octamer’s complete valuation and funding history, request access »

Octamer Patents

Octamer Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-5897799-A Methods for treating viral infections using a compound capable of inhibiting microtubules Inactive 12-Aug-1998
US-6326402-B1 Aromatic ester compound Inactive 12-Aug-1998
US-6303621-B1 Administering diiodo thyronine analogue having no significant hormonal activity and a vinca alkaloid selected from leurosine, vincaleukoblastine, vinblastine, leuroformine, leurosidine, leurocristine, vincristine, deoxy vinblastine Inactive 22-Apr-1998
ES-2181298-T3 Thyroxine analogs that have a non-significant hormonal activity for the treatment of evil tumors. Inactive 23-Oct-1997
AU-1195499-A Thyroxine analogues having no significant hormonal activity to treat malignant tumors Inactive 23-Oct-1997 A61K31/12
To view Octamer’s complete patent history, request access »

Octamer FAQs

  • When was Octamer founded?

    Octamer was founded in 1990.

  • Where is Octamer headquartered?

    Octamer is headquartered in Belvedere Tiburon, CA.

  • What industry is Octamer in?

    Octamer’s primary industry is Biotechnology.

  • Is Octamer a private or public company?

    Octamer is a Private company.

  • What is Octamer’s current revenue?

    The current revenue for Octamer is .

  • How much funding has Octamer raised over time?

    Octamer has raised $821K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »